Maarten van De Klundert

Publikationer
Forskningsbidrag
Populärvetenskap och samverkan

Artiklar

Journal article: JHEP REPORTS. 2024;6(10):101128
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
Ringelhan M; Schuehle S; van de Klundert M; Kotsiliti E; Plissonnier M-L; Faure-Dupuy S; Riedl T; Lange S; Wisskirchen K; Thiele F; Cheng C-C; Yuan D; Leone V; Schmidt R; Huenergard J; Geisler F; Unger K; Alguel H; Schmid RM; Rad R; Wedemeyer H; Levrero M; Protzer U; Heikenwalder M
Article: EUROSURVEILLANCE. 2023;28(48):2300224
The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
Waernberg AW; Braennstroem J; Elvstam O; Gisslen M; Mansson F; Soennerborg A; Klundert MAAVD
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023;61(5):106792
Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
Cena-Diez R; Narayanan A; Ray S; van de Klundert M; Rodriguez JE; Nilvebrant J; Nygren P-A; Vegvari A; van Domselaar R; Sonnerborg A
Article: VIRUSES-BASEL. 2022;14(10):2099
Molecular Epidemiology of HIV-1 in Eastern Europe and Russia
van de Klundert MAA; Antonova A; Di Teodoro G; Diez RC; Chkhartishvili N; Heger E; Kuznetsova A; Lebedev A; Narayanan A; Ozhmegova E; Pronin A; Shemshura A; Tumanov A; Pfeifer N; Kaiser R; Saladini F; Zazzi M; Incardona F; Bobkova M; Sonnerborg A
Article: PLOS PATHOGENS. 2022;18(6):e1010576
Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
Article: CELLULAR MICROBIOLOGY. 2021;23(12):e13399
Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane.
Zhao L; Chen F; Quitt O; Festag M; Ringelhan M; Wisskirchen K; Festag J; Yakovleva L; Sureau C; Bohne F; Aichler M; Bruss V; Shevtsov M; van de Klundert M; Momburg F; Möhl BS; Protzer U
Article: EMBO REPORTS. 2021;22(6):e49568
Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.
Stadler D; Kächele M; Jones AN; Hess J; Urban C; Schneider J; Xia Y; Oswald A; Nebioglu F; Bester R; Lasitschka F; Ringelhan M; Ko C; Chou W-M; Geerlof A; van de Klundert MA; Wettengel JM; Schirmacher P; Heikenwälder M; Schreiner S; Bartenschlager R; Pichlmair A; Sattler M; Unger K; Protzer U
Article: SCIENTIFIC REPORTS. 2020;10(1):14101
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models.
Liu PJ; Harris JM; Marchi E; D'Arienzo V; Michler T; Wing PAC; Magri A; Ortega-Prieto AM; van de Klundert M; Wettengel J; Durantel D; Dorner M; Klenerman P; Protzer U; Giotis ES; McKeating JA
Article: ONCOTARGET. 2018;9(74):33947-33960
Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion.
von Olshausen G; Quasdorff M; Bester R; Arzberger S; Ko C; van de Klundert M; Zhang K; Odenthal M; Ringelhan M; Niessen CM; Protzer U
Article: VIRUSES-BASEL. 2016;8(10):E281-281
Hepatitis B Virus Protein X Induces Degradation of Talin-1.
van de Klundert MAA; van den Biggelaar M; Kootstra NA; Zaaijer HL
Article: JOURNAL OF VIRAL HEPATITIS. 2016;23(3):191-201
Identification of FDA-approved drugs that target hepatitis B virus transcription.
van de Klundert MAA; Zaaijer HL; Kootstra NA
Article: VIROLOGY. 2015;486:94-104
G3BP1 restricts HIV-1 replication in macrophages and T-cells by sequestering viral RNA.
Cobos Jiménez V; Martinez FO; Booiman T; van Dort KA; van de Klundert MAA; Gordon S; Geijtenbeek TBH; Kootstra NA
Article: FUTURE VIROLOGY. 2015;10(4):351-356
Inhibition of histone deacetylases stimulates HBV replication independent of protein X
van de Klundert MAA; Swart M; Zaaijer HL; Kootstra NA
Article: JOURNAL OF VIRAL HEPATITIS. 2012;19(2):e34-e40
Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients.
van de Klundert MAA; Cremer J; Kootstra NA; Boot HJ; Zaaijer HL
Article: PLOS ONE. 2012;7(11):e48940
The hepatitis B virus x protein inhibits thymine DNA glycosylase initiated base excision repair.
van de Klundert MAA; van Hemert FJ; Zaaijer HL; Kootstra NA
Article: PLOS ONE. 2011;6(8):e23392
Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase.
van Hemert FJ; van de Klundert MAA; Lukashov VV; Kootstra NA; Berkhout B; Zaaijer HL

Alla övriga publikationer

Review: PATHOGENS. 2022;12(1):29
Many Ways to Communicate-Crosstalk between the HBV-Infected Cell and Its Environment
Walter AJ; van de Klundert MAA; Jung S
Corrigendum: SCIENTIFIC REPORTS. 2020;10(1):19332
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models.
Liu PJ; Harris JM; Marchi E; D'Arienzo V; Michler T; Wing PAC; Magri A; Ortega-Prieto AM; van de Klundert M; Wettengel J; Durantel D; Dorner M; Klenerman P; Protzer U; Giotis ES; McKeating JA
Meeting abstract: JOURNAL OF HEPATOLOGY. 2018;68:s782
Statins suppress hepatitis B virus replication and reduce hepatoma cell viability by interfering with Rho-GTPases
van de Klundert M; Ringelhan M; Protzer U
Review: VIRUSES-BASEL. 2017;9(7):E193-193
Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection.
Shevtsov M; Zhao L; Protzer U; van de Klundert MAA

Forskningsbidrag

NGS analysis of Lenecapavir resistance in patient samples
Stiftelsen Läkare Mot AIDS
1 January 2024

Artiklar

Alla övriga publikationer

Forskningsbidrag

Nyheter från KI

Kalenderhändelser från KI